Literature DB >> 15530764

Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.

Erna Claes1, Lieve Denayer, Gerry Evers-Kiebooms, Andrea Boogaerts, Eric Legius.   

Abstract

This paper describes the motivation, recall of cancer risks, and illness representations of 40 individuals who had a predictive test for hereditary non-polyposis colorectal cancer (HNPCC) as well as the short-term impact of predictive testing by means of a semi-structured interview and self-report questionnaires. The main motives for predictive testing were early detection of cancer, knowledge of the children's risk and reduction of uncertainty. Overall, recall of cancer risks was good. Measurements of illness representations revealed low perceptions of "threat" of cancer and high confidence in the controllability of the disease. Distress was within normal ranges. Distress decreased significantly from pre- to post-test in non-carriers and did not in carriers. It also decreased in individuals for whom "reducing uncertainty" was a very important motive for the test, not in the others. Although part of the carriers did not have colonoscopies, all carriers intended to have regular colonoscopies in the future.

Entities:  

Mesh:

Year:  2004        PMID: 15530764     DOI: 10.1016/j.pec.2003.11.002

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  37 in total

Review 1.  Communicating genetic risk information within families: a review.

Authors:  Mel Wiseman; Caroline Dancyger; Susan Michie
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 2.  Illness representations, self-regulation, and genetic counseling: a theoretical review.

Authors:  Shoshana Shiloh
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

3.  Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining.

Authors:  Louise A Keogh; Heather Niven; Alison Rutstein; Louisa Flander; Clara Gaff; Mark Jenkins
Journal:  J Behav Med       Date:  2017-02-14

4.  Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Authors:  M J Esplen; N Stuckless; S Gallinger; M Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; J Green; K Butler; H V Petersen; J Wong
Journal:  Clin Genet       Date:  2011-10-03       Impact factor: 4.438

5.  Extended family impact of genetic testing: the experiences of X-linked carrier grandmothers.

Authors:  Anna Lehmann; Beverley S Speight; Lauren Kerzin-Storrar
Journal:  J Genet Couns       Date:  2011-04-14       Impact factor: 2.537

6.  Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Wendy Kohlmann; Samantha L Leaf; Sancy A Leachman
Journal:  J Genet Couns       Date:  2013-12-10       Impact factor: 2.537

7.  Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.

Authors:  Rahul Garg; Joseph Vogelgesang; Kimberly Kelly
Journal:  J Genet Couns       Date:  2015-11-18       Impact factor: 2.537

8.  Cancer genetic counselees' self-reported psychological distress, changes in life, and adherence to recommended surveillance programs 3-7 years post counseling.

Authors:  Afsaneh Hayat Roshanai; Richard Rosenquist; Claudia Lampic; Karin Nordin
Journal:  J Genet Couns       Date:  2009-02-11       Impact factor: 2.537

Review 9.  Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact.

Authors:  Karin M Landsbergen; Judith B Prins; Han G Brunner; Floris W Kraaimaat; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2009-03-28       Impact factor: 2.375

10.  Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling.

Authors:  Eveline M A Bleiker; Fred H Menko; Irma Kluijt; Babs G Taal; Miranda A Gerritsma; Lidwina D V Wever; Neil K Aaronson
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.